Join the Exploding Neoantigen-Based Therapeutics Community
The Neoantigen Summit is the leading industry-focused meeting dedicated to ensuring improved identification, utilization and immune monitoring, to ensure successful clinical development of truly individualized neoantigen-based vaccines and immunotherapies.
The Neoantigen Summit brings together the pioneers supercharging immunotherapy and vaccine development to share key clinical data and insights from sample acquisition, all the way through to vaccine manufacturing and getting a product to market. Receive clinical updates on current programs, regulations for individualized products and scaling down manufacture for personalized therapeutics.
In such a rapidly evolving field, this is the premier platform to benchmark against the industry and network with the crème de la crème of neoantigen therapy developers. Overcome key challenges in prioritizing the right neoantigens to provide an immunogenic response.
As the field has developed, so have we. This year, the Neoantigen Summit will focus extensively on the technologies for identifying neoantigens and the bioinformatics approaches that have been developed to enhance epitope prediction.
Join us to discuss clinical translation and development of neoantigen-based therapies as the industry matures and works to achieve clinical efficacy and proof of concept.